We are an established provider of preclinical consultancy services. Our portfolio of services covers all aspects of the preclinical phase of drug and medical device development. Starting from the identification of high-quality CROs through the scientific evaluation and selection of candidate compounds, on to the planning and execution of entire preclinical development programs, and to the support of regulatory interactions. Our primary focus is a partnership with our clients and the delivery of the highest scientific quality, without ever losing sight of the big picture and economic conditions.